Table of Contents
Nrt Smoking Cessation Aids in Saudi Arabia
Euromonitor International
June 2009
List of Contents and Tables
Executive Summary
Sales
Advance at A Rate on Par With Growth Registered Over the Review Period
Global Economic Downturn Had No Impact on Saudi OTC Healthcare in 2008
Spimaco Maintains Leadership But Other Local Manufacturers Gain in
Importance
Gradual Shift Towards A New OTC Retailing System Continued in
2008
Saudi OTC Healthcare To See A Lower Cagr Over the Forecast Period
Key Trends and Developments
Saudi Economy Continues To Perform in 2008
Despite the Global Financial Crisis
Increasing Penetration of OTC Products
Due To Lower Unit Prices
Health Risks, the Climate and Demographic Factors
Drive Strong Demand
New Product Development Fuelled Rapid Growth of Many
Sectors
Increasing Level of Competition Favours Overall OTC Healthcare
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical
Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
Market
Data
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table
4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC
Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand
Shares by Value 2005-2008
Table 7 Sales of OTC Healthcare by Distribution
Format: % Analysis 2003-2008
Table 8 Sales of OTC Healthcare by Sector and
Distribution Format: % Analysis 2008
Table 9 Forecast Sales of OTC
Healthcare by Sector: Value 2008-2013
Table 10 Forecast Sales of OTC
Healthcare by Sector: % Value Growth 2008-2013
Appendix
OTC
Registration and Classification
Vitamins & Dietary Supplements
Registration and Classification
Self-medication and Preventative
Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches
Definitions
Summary 2 Research Sources
Jamjoom Pharma
Strategic
Direction
Key Facts
Summary 3 Jamjoom Pharma: Key Facts
Summary 4
Jamjoom Pharma: Operational Indicators 2006-2008
Company Background
Production
Competitive Positioning
Summary 5 Jamjoom Pharma:
Competitive Position 2008
Julphar Gulf Pharmaceuticals
Strategic
Direction
Key Facts
Summary 6 Julphar Gulf Pharmaceuticals: Key
Facts
Summary 7 Julphar Gulf Pharmaceuticals: Operational Indicators
2006-2008
Company Background
Production
Competitive
Positioning
Summary 8 Julphar Gulf Pharmaceuticals: Competitive Position
2008
Riyadh Pharma
Strategic Direction
Key Facts
Summary 9
Riyadh Pharma: Key Facts
Summary 10 Riyadh Pharma: Operational Indicators
2006-2008
Company Background
Production
Competitive
Positioning
Summary 11 Riyadh Pharma: Competitive Position 2008
Saudi
Pharmaceutical Industries & Medical Appliances Co (spimaco)
Strategic
Direction
Key Facts
Summary 12 Saudi Pharmaceutical Industries &
Medical Appliances Co (SPIMACO): Key Facts
Summary 13 Saudi Pharmaceutical
Industries & Medical Appliances Co (SPIMACO): Operational Indicators
2006-2008
Company Background
Production
Summary 14 Saudi
Pharmaceutical Industries & Medical Appliances Co (SPIMACO): Production
Statistics 2007
Competitive Positioning
Summary 15 Saudi
Pharmaceutical Industries & Medical Appliances Co (SPIMACO): Competitive
Position 2008
Tabuk Pharmaceutical Manufacturing Co
Strategic
Direction
Key Facts
Summary 16 Tabuk Pharmaceutical Manufacturing Co:
Key Facts
Summary 17 Tabuk Pharmaceutical Manufacturing Co: Operational
Indicators 2006-2008
Company Background
Production
Competitive
Positioning
Summary 18 Tabuk Pharmaceutical Manufacturing Co: Competitive
Position 2008
Headlines
Trends
Competitive Landscape
Prospects
Sector Indicators
Table 11 Number of Smokers by Gender
2003-2008
Sector Data
Table 12 Sales of Smoking Cessation Aids by
Subsector: Value 2003-2008
Table 13 Sales of Smoking Cessation Aids by
Subsector: % Value Growth 2003-2008
Table 14 NRT Gum Flavours: % Value
Breakdown 2006-2008
Table 15 Smoking Cessation Aids Company Shares by
Value 2004-2008
Table 16 Smoking Cessation Aids Brand Shares by Value
2005-2008
Table 17 Forecast Sales of Smoking Cessation Aids by Subsector:
Value 2008-2013
Table 18 Forecast Sales of Smoking Cessation Aids by
Subsector: % Value Growth 2008-2013
| 
View Cart
